Manchester University NHS Foundation Trust
Manchester, M13 9WL, United Kingdom
NCT Number: NCT04324970
The objective of the trial is to assess whether the TOOKIE vest is an effective intervention in reducing line fall out. All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest.
Looking for future studies?
Notify Me0 year–16 year
All sexes
Interventional
Not applicable
Manchester, M13 9WL, United Kingdom
All oncology patients with a tunneled central line will be approached to participate in this study. Following informed consent they will be issued with a TOOKIE vest. Lines will be studied for the duration they are in situ. This will vary depending on the underlying diagnosis and treatment regime. One hundred central line insertions for oncology patients will be prospectively identified and be given the "TOOKIE Vest" to wear. Data will be collated for each group regarding age, gender, diagnosis, type of central access inserted, duration of line, reason for removal, in cases of infection the infected organism will be documented, date of each fall out.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Tookie Vest
Time frame: approximately 1 year
Manchester University NHS Foundation Trust
Other Gov
A Prospective Study to Assess Whether the "Tookie Vest for Oncology" Reduces Central Line Fall Out Rate in the Paediatric Oncology Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03938324
Anemia, Anemia, Hemolytic
Durham, North Carolina, United States
View Trial DetailsNCT07558486
Atrophy, Childhood Cancer
Jimma, Ethiopia
View Trial DetailsNCT06036407
Chemically-Induced Disorders, Childhood Cancer
Bern, Switzerland
View Trial DetailsNCT04714840
Childhood Cancer, Mobility Limitation
Memphis, Tennessee, United States
View Trial Details